The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / October / Rapid Glioma Analysis Could Help Guide Brain Tumor Surgery
Mass Spectrometry Clinical News and Research

Rapid Glioma Analysis Could Help Guide Brain Tumor Surgery

Using a rapid mass spectrometry workflow, researchers identified molecular differences among brain tumors

10/08/2026 3 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Objective:

Assess whether rapid mass spectrometry can distinguish glioma from nontumor brain tissue and classify gliomas by molecular subtype and grade, including in tissue relevant to surgical margins.

Approach:
  • Samples: Researchers analyzed 86 human brain specimens: 78 gliomas and eight nontumor samples.
  • Method: A sterile syringe plunger collected tissue for syringe touch spray tandem mass spectrometry. The analysis compared metabolite ratios and took approximately three minutes.
  • Margin assessment: Researchers tested mixtures of tumor and normal brain tissue to examine how metabolite ratios changed with tumor-cell proportion.
Key Findings:
  • The N-acetylaspartate-to-carnitine ratio distinguished glioma from nontumor tissue with 97% sensitivity, 100% specificity, and 98% accuracy against clinical diagnoses.
  • Ratios involving 2-hydroxyglutarate separated 13 IDH-mutant from 24 IDH-wild-type samples in the study cohort.
  • Several metabolite ratios separated grade 2 from grade 4 tumors and grade 3 from grade 4 tumors in the analyzed samples.
  • In tissue mixtures, ratios involving 2-hydroxyglutarate, glutamate, and carnitine generally changed with tumor-cell proportion. Some mixtures with substantial tumor content fell below the cutoff derived from tumor-core tissue.
Interpretation:

The researchers described the method as a potential source of molecular information during surgery, particularly at tumor margins, rather than a replacement for current standard-of-care procedures.

Limitations:
  • The study analyzed 86 specimens, including only eight nontumor samples.
  • Some mixtures containing substantial tumor content fell below the tumor-core cutoff, indicating that this threshold may miss cancer in heterogeneous margins.
Conclusion:

The study reported rapid differentiation and classification of glioma tissue using metabolite ratios, while noting a potential challenge in applying tumor-core thresholds to surgical margins.

Sources:
  • Article context; study published in Proceedings of the National Academy of Sciences

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Mass Spectrometry
This Week’s Mass Spec News

April 4, 2025

2 min read

 What If Computers Could Smell?
Mass Spectrometry
What If Computers Could Smell?

April 3, 2025

13 min read

Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change

The Analytical Scientist Innovation Awards 2024: #6
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #6

December 3, 2024

3 min read

Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer

The Analytical Scientist Innovation Awards 2024: #4
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.